{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:43:51Z","timestamp":1791297831196,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Endocrinology & Metabolism"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.tem.2009.04.005","type":"journal-article","created":{"date-parts":[[2009,9,11]],"date-time":"2009-09-11T06:03:48Z","timestamp":1252649028000},"page":"380-387","source":"Crossref","is-referenced-by-count":92,"title":["Functional implications of genetic variation in human PPAR\u03b3"],"prefix":"10.1016","volume":"20","author":[{"given":"Ellen H.","family":"Jeninga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Gurnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Kalkhoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tem.2009.04.005_bib1","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.cell.2005.11.026","article-title":"The many faces of PPARgamma","volume":"123","author":"Lehrke","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.tem.2009.04.005_bib2","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/cr.2007.48","article-title":"Fat poetry: a kingdom for PPARgamma","volume":"17","author":"Anghel","year":"2007","journal-title":"Cell Res."},{"key":"10.1016\/j.tem.2009.04.005_bib3","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1146\/annurev.biochem.77.061307.091829","article-title":"Fat and beyond: the diverse biology of PPARgamma","volume":"77","author":"Tontonoz","year":"2008","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.tem.2009.04.005_bib4","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1101\/gad.501108","article-title":"Genome-wide profiling of PPARgamma: RXR and RNA polymerase II occupancy reveals temporal activation of distinct metabolic pathways and changes in RXR dimer composition during adipogenesis","volume":"22","author":"Nielsen","year":"2008","journal-title":"Genes Dev."},{"key":"10.1016\/j.tem.2009.04.005_bib5","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.2337\/db06-0263","article-title":"Adipose tissue: from lipid storage compartment to endocrine organ","volume":"55","author":"Scherer","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2009.04.005_bib6","doi-asserted-by":"crossref","first-page":"41925","DOI":"10.1074\/jbc.M206950200","article-title":"Genetic analysis of adipogenesis through peroxisome proliferator-activated receptor gamma isoforms","volume":"277","author":"Mueller","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2009.04.005_bib7","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/oby.2008.473","article-title":"Posttranslational modifications of PPAR-gamma: fine-tuning the metabolic master regulator","volume":"17","author":"van Beekum","year":"2009","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.tem.2009.04.005_bib8","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0968-0004(01)01800-X","article-title":"Nuclear-receptor interactions on DNA-response elements","volume":"26","author":"Khorasanizadeh","year":"2001","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.tem.2009.04.005_bib9","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/0092-8674(95)90193-0","article-title":"15-Deoxy-delta12,14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma","volume":"83","author":"Forman","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.tem.2009.04.005_bib10","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1210\/me.11.6.779","article-title":"Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay","volume":"11","author":"Krey","year":"1997","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.tem.2009.04.005_bib11","doi-asserted-by":"crossref","first-page":"12953","DOI":"10.1074\/jbc.270.22.12953","article-title":"An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)","volume":"270","author":"Lehmann","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2009.04.005_bib12","doi-asserted-by":"crossref","first-page":"5020","DOI":"10.1021\/jm9804127","article-title":"N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents","volume":"41","author":"Henke","year":"1998","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tem.2009.04.005_bib13","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/25931","article-title":"Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma","volume":"395","author":"Nolte","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.tem.2009.04.005_bib14","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1101\/gad.1263305","article-title":"Corepressors selectively control the transcriptional activity of PPARgamma in adipocytes","volume":"19","author":"Guan","year":"2005","journal-title":"Genes Dev."},{"key":"10.1016\/j.tem.2009.04.005_bib15","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nrm1680","article-title":"Controlling nuclear receptors: the circular logic of cofactor cycles","volume":"6","author":"Perissi","year":"2005","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.tem.2009.04.005_bib16","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jsbmb.2004.12.015","article-title":"Rush hour at the promoter: how the ubiquitin-proteasome pathway polices the traffic flow of nuclear receptor-dependent transcription","volume":"93","author":"Dennis","year":"2005","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.tem.2009.04.005_bib17","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nrm1049","article-title":"How the ubiquitin-proteasome system controls transcription","volume":"4","author":"Muratani","year":"2003","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.tem.2009.04.005_bib18","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jmb.2008.10.039","article-title":"Structural insight into PPARgamma activation through covalent modification with endogenous fatty acids","volume":"385","author":"Waku","year":"2009","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.tem.2009.04.005_bib19","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00210-007-0251-x","article-title":"Peroxisome proliferator activated receptor gamma and oxidized docosahexaenoic acids as new class of ligand","volume":"377","author":"Itoh","year":"2008","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.tem.2009.04.005_bib20","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S1097-2765(00)80448-7","article-title":"Asymmetry in the PPARgamma\/RXRalpha crystal structure reveals the molecular basis of heterodimerization among nuclear receptors","volume":"5","author":"Gampe","year":"2000","journal-title":"Mol. Cell."},{"key":"10.1016\/j.tem.2009.04.005_bib21","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature07413","article-title":"Structure of the intact PPAR-gamma-RXR nuclear receptor complex on DNA","volume":"456","author":"Chandra","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.tem.2009.04.005_bib22","doi-asserted-by":"crossref","first-page":"20108","DOI":"10.1074\/jbc.272.32.20108","article-title":"Polarity and specific sequence requirements of peroxisome proliferator-activated receptor (PPAR)\/retinoid X receptor heterodimer binding to DNA. A functional analysis of the malic enzyme gene PPAR response element","volume":"272","author":"Ijpenberg","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2009.04.005_bib23","doi-asserted-by":"crossref","first-page":"25252","DOI":"10.1074\/jbc.272.40.25252","article-title":"DNA binding properties of peroxisome proliferator-activated receptor subtypes on various natural peroxisome proliferator response elements. Importance of the 5\u2032-flanking region","volume":"272","author":"Juge-Aubry","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2009.04.005_bib24","doi-asserted-by":"crossref","first-page":"27988","DOI":"10.1074\/jbc.273.43.27988","article-title":"A carboxyl-terminal extension of the zinc finger domain contributes to the specificity and polarity of peroxisome proliferator-activated receptor DNA binding","volume":"273","author":"Hsu","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2009.04.005_bib25","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1210\/jc.87.1.408","article-title":"A novel heterozygous mutation in peroxisome proliferator-activated receptor-gamma gene in a patient with familial partial lipodystrophy","volume":"87","author":"Agarwal","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2009.04.005_bib26","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.cmet.2006.09.003","article-title":"Non-DNA binding, dominant-negative, human PPARgamma mutations cause lipodystrophic insulin resistance","volume":"4","author":"Agostini","year":"2006","journal-title":"Cell Metab."},{"key":"10.1016\/j.tem.2009.04.005_bib27","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/47254","article-title":"Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension","volume":"402","author":"Barroso","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.tem.2009.04.005_bib28","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/3099","article-title":"A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity","volume":"20","author":"Deeb","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tem.2009.04.005_bib29","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2350-7-3","article-title":"Peroxisomal proliferator activated receptor-gamma deficiency in a Canadian kindred with familial partial lipodystrophy type 3 (FPLD3)","volume":"7","author":"Francis","year":"2006","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.tem.2009.04.005_bib30","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.2337\/diabetes.51.12.3586","article-title":"PPARG F388L, a transactivation-deficient mutant, in familial partial lipodystrophy","volume":"51","author":"Hegele","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2009.04.005_bib31","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1399-0004.2006.00674.x","article-title":"A frameshift mutation in peroxisome-proliferator-activated receptor-gamma in familial partial lipodystrophy subtype 3 (FPLD3; MIM 604367)","volume":"70","author":"Hegele","year":"2006","journal-title":"Clin. Genet."},{"key":"10.1016\/j.tem.2009.04.005_bib32","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1210\/me.2006-0485","article-title":"Impaired peroxisome proliferator-activated receptor gamma function through mutation of a conserved salt bridge (R425C) in familial partial lipodystrophy","volume":"21","author":"Jeninga","year":"2007","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.tem.2009.04.005_bib33","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1136\/jmg.2007.050567","article-title":"New PPARG mutation leads to lipodystrophy and loss of protein function that is partially restored by a synthetic ligand","volume":"44","author":"Ludtke","year":"2007","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.tem.2009.04.005_bib34","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1210\/jc.2005-2624","article-title":"Peroxisome proliferator-activated receptor-gamma C190S mutation causes partial lipodystrophy","volume":"92","author":"Ludtke","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2009.04.005_bib35","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1210\/jc.2006-1807","article-title":"Familial partial lipodystrophy phenotype resulting from a single-base mutation in deoxyribonucleic acid-binding domain of peroxisome proliferator-activated receptor-gamma","volume":"92","author":"Monajemi","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2009.04.005_bib36","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1056\/NEJM199810013391403","article-title":"Obesity associated with a mutation in a genetic regulator of adipocyte differentiation","volume":"339","author":"Ristow","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tem.2009.04.005_bib37","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/ng926","article-title":"Digenic inheritance of severe insulin resistance in a human pedigree","volume":"31","author":"Savage","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tem.2009.04.005_bib38","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1006\/bbrc.1997.7798","article-title":"Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: identification of a Pro12Ala PPAR gamma 2 missense mutation","volume":"241","author":"Yen","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tem.2009.04.005_bib39","doi-asserted-by":"crossref","first-page":"5655","DOI":"10.1210\/jc.2004-0280","article-title":"A single-base mutation in the peroxisome proliferator-activated receptor gamma4 promoter associated with altered in vitro expression and partial lipodystrophy","volume":"89","author":"Al Shali","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2009.04.005_bib40","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s00125-005-0044-z","article-title":"The in vivo effects of the Pro12Ala PPARgamma2 polymorphism on adipose tissue NEFA metabolism: the first use of the Oxford Biobank","volume":"49","author":"Tan","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.tem.2009.04.005_bib41","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/79839","article-title":"The common PPAR gamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes","volume":"26","author":"Altshuler","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tem.2009.04.005_bib42","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1038\/oby.2007.617","article-title":"Heterogeneous effect of peroxisome proliferator-activated receptor gamma2 Ala12 variant on type 2 diabetes risk","volume":"15","author":"Ludovico","year":"2007","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.tem.2009.04.005_bib43","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1006\/bbrc.2000.2096","article-title":"Inhibitory effect of a proline-to-alanine substitution at codon 12 of peroxisome proliferator-activated receptor-gamma 2 on thiazolidinedione-induced adipogenesis","volume":"268","author":"Masugi","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tem.2009.04.005_bib44","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1055\/s-2003-39235","article-title":"Analysis of the relationship between PPAR-gamma 2 gene variants and severe insulin resistance in obese patients with impaired glucose tolerance","volume":"111","author":"Bluher","year":"2003","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.tem.2009.04.005_bib45","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1055\/s-2002-33072","article-title":"The Pro115Gln polymorphism within the PPAR gamma2 gene has no epidemiological impact on morbid obesity","volume":"110","author":"Hamer","year":"2002","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.tem.2009.04.005_bib46","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/sj.ijo.0801214","article-title":"Variation in the gene for human peroxisome proliferator activated receptor gamma (PPARgamma) does not play a major role in the development of morbid obesity","volume":"24","author":"Evans","year":"2000","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"10.1016\/j.tem.2009.04.005_bib47","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/sj.ijo.0801191","article-title":"The Pro115Gln and Pro12Ala PPAR gamma gene mutations in obesity and type 2 diabetes","volume":"24","author":"Clement","year":"2000","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"10.1016\/j.tem.2009.04.005_bib48","doi-asserted-by":"crossref","first-page":"5128","DOI":"10.1074\/jbc.272.8.5128","article-title":"Transcriptional activation by peroxisome proliferator-activated receptor gamma is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site","volume":"272","author":"Adams","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2009.04.005_bib49","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1126\/science.274.5295.2100","article-title":"Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma","volume":"274","author":"Hu","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.tem.2009.04.005_bib50","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/24634","article-title":"Interdomain communication regulating ligand binding by PPAR-gamma","volume":"396","author":"Shao","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.tem.2009.04.005_bib51","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1210\/en.2003-1271","article-title":"Tyrosine agonists reverse the molecular defects associated with dominant-negative mutations in human peroxisome proliferator-activated receptor gamma","volume":"145","author":"Agostini","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.tem.2009.04.005_bib52","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1210\/me.12.5.609","article-title":"A novel TR beta mutation (R383H) in resistance to thyroid hormone syndrome predominantly impairs corepressor release and negative transcriptional regulation","volume":"12","author":"Clifton-Bligh","year":"1998","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.tem.2009.04.005_bib53","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1210\/me.2006-0401","article-title":"Altered promoter recycling rates contribute to dominant-negative activity of human peroxisome proliferator-activated receptor-gamma mutations associated with diabetes","volume":"21","author":"Li","year":"2007","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.tem.2009.04.005_bib54","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1002\/j.1460-2075.1994.tb06603.x","article-title":"Characterization of the ligand-dependent transactivation domain of thyroid hormone receptor","volume":"13","author":"Barettino","year":"1994","journal-title":"EMBO J."},{"key":"10.1016\/j.tem.2009.04.005_bib55","doi-asserted-by":"crossref","first-page":"14825","DOI":"10.1074\/jbc.271.25.14825","article-title":"Ligand-dependent cross-talk between steroid and thyroid hormone receptors. Evidence for common transcriptional coactivator(s)","volume":"271","author":"Zhang","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2009.04.005_bib56","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.cmet.2008.11.007","article-title":"The Pro12Ala PPARgamma2 variant determines metabolism at the gene-environment interface","volume":"9","author":"Heikkinen","year":"2009","journal-title":"Cell Metab."},{"key":"10.1016\/j.tem.2009.04.005_bib57","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1210\/en.2007-0977","article-title":"The adipogenic acetyltransferase Tip60 targets activation function 1 of PPARgamma","volume":"149","author":"van Beekum","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.tem.2009.04.005_bib58","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.2337\/db06-0389","article-title":"Leptin deficiency unmasks the deleterious effects of impaired peroxisome proliferator-activated receptor gamma function (P465L PPARgamma) in mice","volume":"55","author":"Gray","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2009.04.005_bib59","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1172\/JCI28003","article-title":"PPAR gamma and human metabolic disease","volume":"116","author":"Semple","year":"2006","journal-title":"J. Clin. Invest."},{"issue":"S1","key":"10.1016\/j.tem.2009.04.005_bib60","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1038\/sj.ijo.0802911","article-title":"Lessons from human mutations in PPARgamma","volume":"29","author":"Hegele","year":"2005","journal-title":"Int. J. Obes. (Lond.)"}],"container-title":["Trends in Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104327600900099X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104327600900099X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T10:07:00Z","timestamp":1558519620000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104327600900099X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":60,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S104327600900099X"],"URL":"https:\/\/doi.org\/10.1016\/j.tem.2009.04.005","relation":{},"ISSN":["1043-2760"],"issn-type":[{"value":"1043-2760","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}